Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial*

Daniel P. Schuster, John P. Pribble, Eileen Coyne et al.|Critical Care Medicine|2003

Cited by 82